Rosebud Biotech

With over 30 years in the biotechnology industry, Daniel Gold is looking to bring his experience to helping companies succeed as a member of their SAB's and BOD's. After obtaining his Ph.D. in biochemical engineering from MIT, he has worked on many different systems in both industrial and pharmaceutical biotechnology. His last ten years have included an effort towards developing AAV gene therapy using both insect and mammalian production. He has served as a CEO at an early stage company as well as led technical operations and process science functions. He has also served on several SAB's and BOD's.